HRP20030220B1 - Bicyclic heteroaromatic compounds - Google Patents

Bicyclic heteroaromatic compounds

Info

Publication number
HRP20030220B1
HRP20030220B1 HR20030220A HRP20030220A HRP20030220B1 HR P20030220 B1 HRP20030220 B1 HR P20030220B1 HR 20030220 A HR20030220 A HR 20030220A HR P20030220 A HRP20030220 A HR P20030220A HR P20030220 B1 HRP20030220 B1 HR P20030220B1
Authority
HR
Croatia
Prior art keywords
bicyclic heteroaromatic
heteroaromatic compounds
thieno
methylthio
carboxamide
Prior art date
Application number
HR20030220A
Other languages
English (en)
Croatian (hr)
Inventor
Marius Timmers Cornelis
Frederik Johan Karstens Willem
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of HRP20030220A2 publication Critical patent/HRP20030220A2/hr
Publication of HRP20030220B1 publication Critical patent/HRP20030220B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20030220A 2000-09-22 2003-03-21 Bicyclic heteroaromatic compounds HRP20030220B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00203287 2000-09-22
PCT/EP2001/010743 WO2002024703A1 (fr) 2000-09-22 2001-09-17 Composés hétéroaromatique bicyclique

Publications (2)

Publication Number Publication Date
HRP20030220A2 HRP20030220A2 (en) 2003-06-30
HRP20030220B1 true HRP20030220B1 (en) 2011-10-31

Family

ID=8172046

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030220A HRP20030220B1 (en) 2000-09-22 2003-03-21 Bicyclic heteroaromatic compounds

Country Status (32)

Country Link
US (2) US7229990B2 (fr)
EP (2) EP1322651B1 (fr)
JP (1) JP4977940B2 (fr)
KR (1) KR100860040B1 (fr)
CN (1) CN1247594C (fr)
AR (1) AR030784A1 (fr)
AT (1) ATE384726T1 (fr)
AU (2) AU2002213929B2 (fr)
BR (1) BR0113987A (fr)
CA (1) CA2422054C (fr)
CY (1) CY1107308T1 (fr)
CZ (1) CZ297136B6 (fr)
DE (1) DE60132607T2 (fr)
DK (1) DK1322651T3 (fr)
EC (1) ECSP034523A (fr)
ES (1) ES2299524T3 (fr)
HK (1) HK1054942A1 (fr)
HR (1) HRP20030220B1 (fr)
HU (1) HU229422B1 (fr)
IL (2) IL154624A0 (fr)
IS (1) IS2531B (fr)
MX (1) MXPA03002478A (fr)
NO (1) NO328683B1 (fr)
NZ (1) NZ524444A (fr)
PE (1) PE20020537A1 (fr)
PL (1) PL207755B1 (fr)
PT (1) PT1322651E (fr)
RU (1) RU2271360C2 (fr)
SK (1) SK287554B6 (fr)
TW (1) TWI290143B (fr)
WO (1) WO2002024703A1 (fr)
ZA (1) ZA200301588B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002213929B2 (en) * 2000-09-22 2006-04-13 Merck Sharp & Dohme B.V. Bicyclic heteroaromatic compounds
TW200407127A (en) 2002-08-21 2004-05-16 Astrazeneca Ab Chemical compounds
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
BRPI0610133A2 (pt) * 2005-05-17 2010-06-01 Schering Corp heterociclos como agonistas de receptor de ácido nicotìnico para o tratamento de dislipidemia
US7737155B2 (en) * 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
CA2652061A1 (fr) * 2006-05-17 2007-11-29 Marvin C. Gershengorn Ligands de pyrimidine de faible poids moleculaire destines a moduler des recepteurs hormonaux
CN102015704A (zh) 2008-04-29 2011-04-13 霍夫曼-拉罗奇有限公司 Jnk的嘧啶基吡啶酮抑制剂
EP2358684B8 (fr) 2008-10-20 2014-10-22 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Agonistes de faible poids moléculaire du récepteur de l hormone stimulatrice de la thyroïde (tshr)
EP2563777A4 (fr) 2010-04-08 2013-09-04 Us Health Agonistes inverses et antagonistes neutres pour récepteur du tsh
CN103974955B (zh) 2011-08-23 2018-06-19 阿萨纳生物科技有限责任公司 嘧啶并-哒嗪酮化合物及其用途
CN113680386B (zh) * 2021-08-23 2023-08-11 深圳湾实验室坪山生物医药研发转化中心 氮杂环卡宾-方酰胺双功能催化剂及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995034563A1 (fr) * 1994-06-16 1995-12-21 Pfizer Inc. Pyrazolo et pyrrolopyridines
WO2000061586A1 (fr) * 1999-04-08 2000-10-19 Akzo Nobel N.V. Composes heteroaromatiques bicycliques utiles en tant qu'agonistes de l'hormone luteinisante (lh)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044041A1 (fr) * 1996-05-20 1997-11-27 Merck & Co., Inc. Antagonistes de la gonadoliberine
AU2002213929B2 (en) * 2000-09-22 2006-04-13 Merck Sharp & Dohme B.V. Bicyclic heteroaromatic compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995034563A1 (fr) * 1994-06-16 1995-12-21 Pfizer Inc. Pyrazolo et pyrrolopyridines
WO2000061586A1 (fr) * 1999-04-08 2000-10-19 Akzo Nobel N.V. Composes heteroaromatiques bicycliques utiles en tant qu'agonistes de l'hormone luteinisante (lh)

Also Published As

Publication number Publication date
NO328683B1 (no) 2010-04-26
DE60132607T2 (de) 2009-01-29
KR100860040B1 (ko) 2008-09-25
SK287554B6 (sk) 2011-01-04
NO20031314L (no) 2003-03-21
DE60132607D1 (de) 2008-03-13
EP1886999A2 (fr) 2008-02-13
ES2299524T3 (es) 2008-06-01
PE20020537A1 (es) 2002-06-20
ECSP034523A (es) 2003-04-25
PL360675A1 (en) 2004-09-20
NZ524444A (en) 2004-03-26
US7618963B2 (en) 2009-11-17
EP1886999A3 (fr) 2008-03-12
HU229422B1 (hu) 2013-12-30
IS2531B (is) 2009-07-15
US20070197527A1 (en) 2007-08-23
AR030784A1 (es) 2003-09-03
WO2002024703A1 (fr) 2002-03-28
BR0113987A (pt) 2003-08-12
HRP20030220A2 (en) 2003-06-30
AU2002213929B2 (en) 2006-04-13
HUP0302648A2 (hu) 2003-11-28
JP2004509896A (ja) 2004-04-02
EP1886999A8 (fr) 2010-08-04
DK1322651T3 (da) 2008-06-02
IL154624A0 (en) 2003-09-17
CZ2003828A3 (cs) 2003-08-13
US7229990B2 (en) 2007-06-12
ATE384726T1 (de) 2008-02-15
ZA200301588B (en) 2004-06-22
CN1462273A (zh) 2003-12-17
HK1054942A1 (en) 2003-12-19
EP1322651B1 (fr) 2008-01-23
CY1107308T1 (el) 2012-11-21
KR20030040483A (ko) 2003-05-22
CA2422054A1 (fr) 2002-03-28
EP1322651A1 (fr) 2003-07-02
CA2422054C (fr) 2011-01-11
RU2271360C2 (ru) 2006-03-10
IL154624A (en) 2009-09-01
SK3312003A3 (en) 2003-08-05
JP4977940B2 (ja) 2012-07-18
NO20031314D0 (no) 2003-03-21
CZ297136B6 (cs) 2006-09-13
AU1392902A (en) 2002-04-02
IS6732A (is) 2003-02-28
TWI290143B (en) 2007-11-21
MXPA03002478A (es) 2004-05-05
PT1322651E (pt) 2008-02-28
US20030225113A1 (en) 2003-12-04
CN1247594C (zh) 2006-03-29
HUP0302648A3 (en) 2004-11-29
PL207755B1 (pl) 2011-01-31

Similar Documents

Publication Publication Date Title
HRP20010573B1 (en) Tricyclic inhibitors of poly(adp-ribose) polymerases
PT1289992E (pt) Nova forma cristalina de um composto de triazolo (4,5-d) pirimidina
CA2416867A1 (fr) Cyclopentanoindoles, compositions contenant de tels composes et procedes de traitement
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
GB0124627D0 (en) Novel compounds
HRP20030220B1 (en) Bicyclic heteroaromatic compounds
MA26824A1 (fr) 5-(2-substitué-5-hétérocyclylsulfonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidine-7-ones servant d'inhibiteurs de phosphodiestérase.
DK1379239T3 (da) N(2-aryl-ethyl)-benzyl-aminer som antagonister af 5 HT6 receptoren
HRP20010117B1 (en) Novel salt form of pantoprazole
DZ3266A1 (fr) Pyrido[2,3-d]pyrimidine-2,7-diamine inhibiteurs de kinase
MXPA03009317A (es) Derivados de dihidro-benzo(b)[1,4]diazepin-2-ona como antagonistas i del receptor metabotropico de glutamaco (mglur2).
MXPA02011319A (es) Analogos antitumorales de ecteinascidina 743.
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
HRP20010238B1 (en) 2-methyl-thieno-benzodiazepine formulation
DE60005031D1 (de) Partikel mit kontrollierter freisetzungsrate
HK1061026A1 (en) 3,7-Diazabicyclo 3.3.1Ü formulations as antiarhythmic compounds
AU5539899A (en) Novel triazolo(4,5-(d))pyrimidine compounds
TR199901017A2 (xx) B�cek ilac� terkibi.
MXPA03004498A (es) Uso de pirazolo (4,3-d)pirimidinas.
GB2418915B (en) Fragrance compositions comprising benzo[4,5]thieno[3,2-B]pyran-2-one
AU9069201A (en) Interheteroaryl 7-oxabicyclic (2.2.1)heptane oxazoles as prostaglandin F<sub>2alpha</sub> antagonists
MXPA03009209A (es) Formulaciones de 3,7-diazabiciclo-[3.3.1] como compuestos anti-arritmicos.
PL356668A1 (en) Novel substituted pyrazolo[4,3-e
SI0915087T1 (en) Sulfonamide substituted fused five-membered ring compounds, their use as medicaments as well as pharmaceutical compositions containing them
IL144126A0 (en) A method of altering the specificity of cyclooxygenase-inhibiting compounds

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: N.V. ORGANON, NL

B1PR Patent granted
PPPP Transfer of rights

Owner name: MSD OSS B.V., NL

PPPP Transfer of rights

Owner name: ORGANON BIOSCIENCES NEDERLAND B.V., NL

ODRP Renewal fee for the maintenance of a patent

Payment date: 20140826

Year of fee payment: 14

PBON Lapse due to non-payment of renewal fee

Effective date: 20150917